Douglas McNeel is an Oncology physician affiliated with University of Wisconsin–Madison. OpenAlex indexes 333 publications with 7,315 citations (h-index 51); ClinicalTrials.gov lists 14 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
600 Highland Ave
Madison, WI 53792
Telephone
608-265-1700Provider last certified this registry record 14 Jan 2021.
Clinical trials
- Trial of pTVG-HP+Nivo+Targeted Ablation of Resistant Lesions in Non-Castrate RecurrentOMPC
Sponsor: University of Wisconsin, Madison
- Novel ACK1 Inhibitor (R)-9b in Patients With Prostate Cancer
Sponsor: TechnoGenesys, Inc.
- pTVG-HP DNA Vaccine With or Without pTVG-AR DNA Vaccine and Pembrolizumab in Patients With Castration-Resistant, Metastatic Prostate Cancer
Sponsor: University of Wisconsin, Madison
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Exelixis Inc.Program year20241 payment
- Janssen Research & Development, LLCProgram year20222 payments
- Janssen Research & Development, LLCProgram year20212 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
53.8%Gonadotropin Releasing Hormone Receptor Antagonist22.6%Orgovyx100%Part D<11 patientsCytochrome P450 17A1 Inhibitor19.4%Abiraterone Acetate100%Part D<11 patients+ 1 more class in this area
Metabolism & gastrointestinal
33.3%Corticosteroid33.3%Prednisone100%Part D<11 patientsHormonal (systemic)
12.9%l-Thyroxine12.9%Levothyroxine Sodium100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
9 NIH research awards on record, funded 2002–2025 per NIH RePORTER. The latest:
- Project 2: Androgen deprivation as an immune modulating therapy in combination with targeted immunotherapy of prostate cancer
University of Wisconsin-Madison
FY2025$366,237P50CA269011
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Immune system and intestinal microbiota determine efficacy of androgen deprivation therapy against prostate cancer
Journal for ImmunoTherapy of Cancer
2022 - Reversible epigenetic alterations regulate class I HLA loss in prostate cancer
Communications Biology
2022 - Phase 2 trial of T-cell activation using MVI-816 and pembrolizumab in patients with metastatic, castration-resistant prostate cancer (mCRPC)
Journal for ImmunoTherapy of Cancer
2022
Similar KOLs
Other experts from the same institution or the same specialty.
William Busse, MD
University of Wisconsin–Madison
David Andes, MD
University of Wisconsin–Madison
Neil Binkley, MD
University of Wisconsin–Madison
Robert Lemanske, MD
University of Wisconsin–Madison
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”